切换至 "中华医学电子期刊资源库"
高级检索
中华妇幼临床医学杂志(电子版)

中华妇幼临床医学杂志(电子版) ›› 2012, Vol. 08 ›› Issue (05) : 585 -587. doi: 10.3877/cma.j.issn.1673-5250.2012.05.007

所属专题： 文献；

论著

重组人生长激素对身材矮小的小于胎龄儿身高的促增长作用
陈丽娜1,*,*(), 向承发2   
  1. 1. 610072　成都，四川省医学科学院·四川省人民医院儿科
    2. 四川大学华西第二医院儿科
  • 收稿日期:2012-06-20 修回日期:2012-08-18 出版日期:2012-10-01
  • 通信作者: 陈丽娜

Effects of Recombinant Human Growth Hormone on Stature in Short Children Born Small for Gestational Age

Li-na CHEN1(), Chen-fa XIANG2   

  1. 1. Department of Pediatrics, Sichuan Academy of Medical Science and Provincial People's Hospital, Chengdu 610072, Sichuan Province, China
  • Received:2012-06-20 Revised:2012-08-18 Published:2012-10-01
  • Corresponding author: Li-na CHEN
  • About author:
    (Corresponding author: CHEN Li-na, Email: )
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

陈丽娜, 向承发. 重组人生长激素对身材矮小的小于胎龄儿身高的促增长作用[J]. 中华妇幼临床医学杂志(电子版), 2012, 08(05): 585-587.

Li-na CHEN, Chen-fa XIANG. Effects of Recombinant Human Growth Hormone on Stature in Short Children Born Small for Gestational Age[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2012, 08(05): 585-587.

目的

探讨重组人生长激素(rhGH)治疗对身材矮小的小于胎龄(SGA)儿身高增长的疗效。

方法

选择2008年1月至2011年10月因身材矮小于四川省人民医院儿科和四川大学华西第二医院儿科门诊就诊，并接受rhGH治疗的20例身材矮小的SGA儿为研究对象。其平均年龄为(8.95±4.06)岁，rhGH治疗剂量为(0.15～0.20)U/(kg·d)，睡前皮下注射，疗程为2.3～18.0个月。对患儿治疗前、后身高(Ht)，身高标准差积分(HtSDS)及生长速率(HV)进行统计学分析(本研究遵循的程序符合四川省医学科学院与四川大学华西第二医院人体试验委员会所制定的伦理学标准，得到该委员会批准，并与受试对象监护人签署临床研究知情同意书)。

结果

20例身材矮小的SGA儿rhGH治疗前、后的Ht，HtSDS及治疗前1年与治疗后1年的HV分别为(110.34±22.1)cm与(115.88±22.29)cm，－4.31±1.47与－3.71±1.36，(4.06±0.61)cm/年与(9.86±4.01)cm/年，且差异均有统计学意义(P<0.05)。

结论

rhGH治疗对身材矮小的SGA儿Ht增长具有明显疗效。

关键词: 小于胎龄, 重组人生长激素, 身高, 儿童
Objective

To explore the therapeutic effects of recombinant human growth hormone (rhGH)on children with short stature born small for gestational age (SGA).

Methods

This was a prospective observational study with institutional ethics approval and written maternal consent. A total of 20 children with short stature born in SGA were selected in Department of Pediatrics, Sichuan Provincial People's Hospital and West China Second Hospital, Sichuan University from January 2008 to October 2011. Their average age was (8.95±4.06) years old. Each child was treated with rhGH by subcutaneous injection every night before sleep, and the dosage was (0.15-0.20) U/(kg·d) for 2.3-18.0 months. The height (Ht), height standard deviation score (HtSDS)and height velocity (HV) were statistically analyzed before and after rhGH treatment.

Results

Before and after rhGH treatment, there had significant differences in the Ht[(110.34±22.1) cm vs.(115.88±22.29) cm], HtSDS (-4.31±1.47 vs. -3.71±1.36)and HV[(4.06±0.6) cm/year vs. (9.86±4.01)cm/year](P<0.05).

Conclusions

rhGH can play a significant role in promoting growth of children with short stature born in SGA.

Key words: small for gestational age, recombinant human growth hormone, stature, child
表1 20例身材矮小SGA儿的rhGH治疗疗效(±s)
Table 1 Comparison of Ht, HtSDS and HV before and after rhGH treatment (±s)
时间 Ht(cm) HtSDS HV(cm/年)
治疗前 110.34±22.10 －4.31±1.47 4.06±0.61
治疗后 115.88±22.29 －3.71±1.36 9.86±4.01
t －5.083 －3.972 －5.834
P <0.01 <0.01 <0.01
[1]
Yan C, Wang MD. Pediatric endocrinology. 2 nd ed[M]. Beijing:People's Medical Publishing House, 2006, 59-61.
[2]
Wang QH, Yang YJ, Wei KL, et al. Current situation investigation and analysis of SGA in China[J]. Chin J Pract Pediatr, 2009, 24(3):177-180.
[3]
De Zegher F, Hokken - Koelega A. Growth hormone therapy for children born small for gestational age:High gain is less dose dependent over the long term than over the short term[J]. Pediatrics, 2005, 115(4):458-462.
[4]
Henwood JM, Grimberg A, Moshang T. Expanded spectrum of recombinant human growth hormone therapy[J]. Curr Opin Pediatr, 2002, 14:437-442.
[5]
The Subspecialty Group of Endocrinology, Hereditary and Metabolic Diseases, the Society of Pediatrics, Chinese Medical Association. Guideline for diagnosis and treatment of children with short stature[J]. Chin J Pediatr, 2008, 46(6):428-430.
[6]
Li H, Ji CY, Zong XN, et al. Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years[J]. Chin J Pediatr, 2009, 47(7):487-492.
[7]
Gong CX, Huang H. Diagnosis and treatment of small for gestational age[J]. J Appl Clin Pediatr, 2009, 24(20):1622-1624.
[8]
Cianfarani S, Ladaki C, Geremia C. Hormonal regulation of postnatal growth in children born small for gestational age[J]. Horm Res, 2006, 65(suppl 13):S70-S74.
[9]
Trivin C, Souberbielle JC, Aubertin G, et al. Diagnosis of idiopathic growth hormone deficiency:Contributions of data on the A cidlabile subunit, insulin-like growth factor(IGF)- Ⅰ, and IGF-Ⅰ, and IGFBP-3[J]. J Pediatr Endocrinol Metab, 2006, 19 (4):481-489.
[10]
Hokken-Koelega A, Van Pareren Y, Nicolette A. Effects of growth hormone treatment on cognitive function and head circumference in children born small for gestational age[J]. Horm Res, 2005, 64(suppl 3):S95-S99.
[11]
Paul S, Paul C, Ieuan H, et al. Small for gestational age:Short stature and beyond[J]. Endcrine Rev, 2007, 28 (2):219-251.
[12]
Dahlgren J, Wikland KA. Final height in short children born small for gestational age treated with growth hormone[J]. Pediatr Res, 2005, 57:216-222.
[13]
De Zegher F, Ong KK, Dunger DB, et al. Growth hormone therapy in short children born small for gestational age[J]. Horm Res, 2006, 65(suppl 13):S145-S152.
[1] 张璇, 马宇童, 苗玉倩, 张云, 吴士文, 党晓楚, 陈颖颖, 钟兆明, 王雪娟, 胡淼, 孙岩峰, 马秀珠, 吕发勤, 寇海燕. 超声对Duchenne肌营养不良儿童膈肌功能的评价[J]. 中华医学超声杂志（电子版）, 2023, 20(10): 1068-1073.
[2] 张宝富, 俞劲, 叶菁菁, 俞建根, 马晓辉, 刘喜旺. 先天性原发隔异位型肺静脉异位引流的超声心动图诊断[J]. 中华医学超声杂志（电子版）, 2023, 20(10): 1074-1080.
[3] 韩丹, 王婷, 肖欢, 朱丽容, 陈镜宇, 唐毅. 超声造影与增强CT对儿童肝脏良恶性病变诊断价值的对比分析[J]. 中华医学超声杂志（电子版）, 2023, 20(09): 939-944.
[4] 刘婷婷, 林妍冰, 汪珊, 陈幕荣, 唐子鉴, 代东伶, 夏焙. 超声衰减参数成像评价儿童代谢相关脂肪性肝病的价值[J]. 中华医学超声杂志（电子版）, 2023, 20(08): 787-794.
[5] 周钰菡, 肖欢, 唐毅, 杨春江, 周娟, 朱丽容, 徐娟, 牟芳婷. 超声对儿童髋关节暂时性滑膜炎的诊断价值[J]. 中华医学超声杂志（电子版）, 2023, 20(08): 795-800.
[6] 米洁, 陈晨, 李佳玲, 裴海娜, 张恒博, 李飞, 李东杰. 儿童头面部外伤特点分析[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 511-515.
[7] 李维, 莫俊俏. 儿童呼吸道耐药流感嗜血杆菌基因型鉴定及耐药分析对抗菌药物治疗选择的意义[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(05): 315-323.
[8] 邬文莉, 万约翰, 高梓君, 黎凡. 外科手术联合口服西罗莫司治疗儿童口腔颌面部淋巴管畸形[J]. 中华口腔医学研究杂志(电子版), 2023, 17(05): 345-352.
[9] 王蕾, 王少华, 牛海珍, 尹腾飞. 儿童腹股沟疝围手术期风险预警干预[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 768-772.
[10] 李芳, 许瑞, 李洋洋, 石秀全. 循证医学理念在儿童腹股沟疝患者中的应用[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 782-786.
[11] 闵筱兰, 周洁超, 陈振添. 健康管理联合心理干预用于腹腔镜腹股沟疝手术患儿术后效果观察[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 657-661.
[12] 吕垒, 冯啸, 何凯明, 曾凯宁, 杨卿, 吕海金, 易慧敏, 易述红, 杨扬, 傅斌生. 改良金氏评分在儿童肝豆状核变性急性肝衰竭肝移植手术时机评估中价值并文献复习[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 661-668.
[13] 卓少宏, 林秀玲, 周翠梅, 熊卫莲, 马兴灶. CD64指数、SAA/CRP、PCT联合检测在小儿消化道感染性疾病鉴别诊断中的应用[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 505-509.
[14] 刘笑笑, 张小杉, 刘群, 马岚, 段莎莎, 施依璐, 张敏洁, 王雅晳. 中国学龄前儿童先天性心脏病流行病学研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1021-1024.
[15] 李静, 张玲玲, 邢伟. 兴趣诱导理念用于小儿手术麻醉诱导前的价值及其对家属满意度的影响[J]. 中华临床医师杂志(电子版), 2023, 17(07): 812-817.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号